These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 1714865
1. [Paradoxical bleeding as a complication of the treatment of hemophilia with factor VIII and factor IX preparations]. Sutor AH. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):595-9. PubMed ID: 1714865 [Abstract] [Full Text] [Related]
5. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease. Brinkhous KM. Wien Klin Wochenschr; 1982 Oct 15; 94(19):509-14. PubMed ID: 6818773 [Abstract] [Full Text] [Related]
6. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor]. Klukowska A, Zieleniewska B. Acta Haematol Pol; 1994 Oct 15; 25(4):349-54. PubMed ID: 7847036 [Abstract] [Full Text] [Related]
8. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII]. Hrubisková K. Folia Haematol Int Mag Klin Morphol Blutforsch; 1980 Oct 15; 107(4):672-82. PubMed ID: 6162735 [Abstract] [Full Text] [Related]
19. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Blood Coagul Fibrinolysis; 2009 Mar 15; 20(2):89-100. PubMed ID: 19786936 [Abstract] [Full Text] [Related]